Plasmidsaurus Unveils Rapid RNA-Seq Service at ASHG Conference

Plasmidsaurus has introduced a groundbreaking RNA sequencing (RNA-Seq) service tailored for Illumina short read applications, enhancing gene expression analysis through a streamlined process similar to their plasmid sequencing approach. This innovation was showcased at the ASHG Annual Conference in Boston, where attendees had the opportunity to interact with Plasmidsaurus scientists and preview new analytics tools for RNA-Seq.

According to Mark Budde, co-founder and CEO of Plasmidsaurus, the aim is to simplify access to quality transcriptomics data. He stated, “Getting good transcriptomics data shouldn’t take weeks of hassle. Send us cells and we’ll get you answers.” This approach promises accelerated RNA expression profiling, allowing users to transform crude cell preparations into fully analyzed data in as little as three days.

Plasmidsaurus positions its RNA-Seq service as highly accessible. Cultured cells can be submitted at room temperature using Zymo DNA/RNA shield via a convenient network of drop-boxes. Budde emphasized that users do not need to possess bioinformatics expertise to engage with the service; they can easily create and explore gene expression experiments directly on the results page.

Feedback from the scientific community highlights the service’s potential. Molly Gasperini, associate director of genome engineering at the Allen Institute, praised the launch, saying, “Huge kudos to Plasmidsaurus for this incredibly fast, affordable service.”

The advancements in RNA-Seq technology are expected to significantly benefit pharmaceutical and biotechnology companies requiring immediate feedback on drug candidates or genome editing processes. Jim Stapleton, co-founder and CTO of Plasmidsaurus, noted, “Every day we see how seamless sequencing services unlock new applications, better workflows, and accelerated science. We can’t wait to see what researchers can do with faster and more accessible RNA-Seq.”

In addition to the RNA-Seq service, Plasmidsaurus has made strides in other areas of genomics. Recently, they launched an overnight microbiome amplicon sequencing service aimed at expediting microbiology research. They also introduced a rapid, low-input AAV genome sequencing service to support gene therapy research and development. Furthermore, the company opened its tenth global sequencing lab located in Singapore, expanding its operational reach.

Plasmidsaurus continues to innovate in the field of sequencing, aiming to facilitate scientific advancements and enhance the research capabilities of institutions and companies worldwide.